Haemonetics
HAE
#3421
Rank
โ‚น364.65 B
Marketcap
โ‚น7,569
Share price
0.16%
Change (1 day)
7.79%
Change (1 year)

EPS for Haemonetics (HAE)

EPS in 2025 (TTM): โ‚น297.67

According to Haemonetics's latest financial reports the company's current EPS (TTM) is โ‚น310.73. In 2024 the company made an earnings per share (EPS) of โ‚น231.23 an increase over its 2023 EPS that were of โ‚น225.74.

EPS history for Haemonetics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น297.6728.73%
2024โ‚น231.232.43%
2023โ‚น225.7433.73%
2022โ‚น168.81332.49%
2021โ‚น39.03
2018โ‚น80.68-363.15%
2017-โ‚น30.66-207.1%
2016โ‚น28.63-132.28%
2015-โ‚น88.68-269%
2014โ‚น52.47-20%
2013โ‚น65.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,564 403.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
โ‚น695.23 123.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚น502.26 61.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus
CERS
-โ‚น7.21-102.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น59.51-119.15%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚น694.31 123.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น941.35 202.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
โ‚น327.33 5.34%๐Ÿ‡ฎ๐Ÿ‡ช Ireland